NYSE •
Healthcare •
Biotechnology •
Quote as of 05/22/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization78.39 mln
Float31.70 mln
Earnings Date08/13/2026
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
11.52
Transformational upside
Relative Strength
85
/ 100
Strongly outperforming
Debt / Equity
-0.12
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
OS Therapies is a Maryland-based medical company working to develop new treatments for bone cancer and other solid tumors. Its main focus is on two promising therapies: an immune-based treatment for osteosarcoma that is ready to use without customization, and a targeted drug delivery technology designed to release medication more precisely within the body. Founded in 2018, the company is still in the clinical development phase and operates primarily in the United States.
